Basilea’s antibiotic trials (and tribulations) may resolve in Q4
22 August 2011
Pial Ganguli
Please Login to read the full article.
22 August 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Rib-X Pharma files for IPO to finance antibiotics providing superior coverage
- Bayer licenses non-US/EU rights to Trius' torezolid for $25M up front
- Enanta, Cubrc win multimillion NIAID contracts to pursue antibiotics
- Cempra dives into tough IPO pool, filing $86M IPO for Phase II antibiotics
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
